The Ontario Superior Court dismisses a generic manufacturer’s claim for damages under section 8 of the PM(NOC) Regulations
Supreme Court denies leave to appeal in generic Statute of Monopolies case
ONCA Confirms Generics Limited to Section 8 Damages in the Face of an Innovator’s Legitimate Exercise of Rights under the PM(NOC) Regulations
Amendments to the Federal Courts Rules
Pharma in Brief: The 2021 Year in Review
ONSC dismisses Apotex’s second monopolies action
Amendments to the Federal Courts Rules
Proposed amendments to the PM(NOC) Regulations: Patents claiming different salt forms of medicinal ingredients eligible for inclusion on the Patent Register
Ontario Superior Court summarily dismisses Apotex’s novel monetary claims under Statutes of Monopolies, Trademarks Act, and at common law
Subscribe: Subscribe via RSS
Blogs
Firm/Org